| NCT ID | NCT02245763 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American College of Cardiology |
| Condition | Mitral Valve Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2013-11 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2013-11 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter mitral valve repair (TMVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of mitral valve disease.
Eligibility Criteria
Inclusion Criteria: * All patients Exclusion Criteria: * Patients who cannot tolerate procedural anticoagulation or post procedural anti-platelet regimen * Active endocarditis of the mitral valve * Rheumatic mitral valve disease * Evidence of intracardiac, inferior vena cava (IVC) or femoral venous thrombus
Contact & Investigator
Frequently Asked Questions
Who can join the NCT02245763 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, studying Mitral Valve Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02245763 currently recruiting?
Yes, NCT02245763 is actively recruiting participants. Contact the research team at jmichael@acc.org for enrollment information.
Where is the NCT02245763 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT02245763 clinical trial?
NCT02245763 is sponsored by American College of Cardiology. The trial plans to enroll 4,000 participants.